search
Back to results

Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia

Primary Purpose

Plasmodium Infection

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Personal protection package
Sponsored by
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Plasmodium Infection focused on measuring malaria, prevention, vector, migrant, elimination, vivax, falciparum, community-delivered, intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion:

Mobile and migrant individuals aged 18 years and over in selected villages including:

  • Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups)
  • Seasonal agricultural laborers
  • Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo)
  • Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.)
  • Formal and informal cross-border migrant workers

For qualitative research component, local health stakeholders meeting the following criteria will be eligible:

  • Aged 18 years and over
  • The local health stakeholders such as health centre staff, Operational District Malaria Supervisor (ODMS), and Provincial Malaria Supervisor (PMS), and basic health staff such as malaria unit staff in health centres, midwives, health assistants, district health officers and district focal person from CMPE and CNM
  • Health staff members from HPA and Lao malaria community service organisations

Exclusion:

A village will be excluded from the study if:

The village has an VHV/VMW program operated by any organizations other than CMPE, CNM, HPA, malaria CSOs in Lao PDR The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020) The village has no MMPs The village has no VHV/VMW The village has a government health facility for provision of malaria services

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Personal protection package

    Control

    Arm Description

    A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and mobile and migrant population-tailored behavioural change communication (BCC) package

    No personal protection package

    Outcomes

    Primary Outcome Measures

    Plasmodium spp. infection diagnosed by RDT
    Change in the number of Plasmodium spp. infections detected by RDT per week per village

    Secondary Outcome Measures

    Symptomatic malaria diagnosed by RDT
    Change in the number of symptomatic Plasmodium spp. infections detected by RDT per week per village
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on RDT cassette samples
    Change in the prevalence of Plasmodium spp. infection as determined by polymerase chain reaction (PCR) from RDT cassette samples
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on dried blood spot samples
    Change in the prevalence of Plasmodium spp. infection as determined by polymerase chain reaction (PCR) from dried blood spot (DBS) samples
    Plasmodium spp. infections with drug resistance mutations
    Change in the prevalence of Plasmodium spp. infection with drug resistance mutations.
    Prevalence of antibodies to Plasmodium spp.
    Prevalence of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Levels of antibodies to Plasmodium spp.
    Levels of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Prevalence of antibodies to vector salivary antigens
    Levels of antibody biomarkers of vector exposure
    Levels of antibodies to vector salivary antigens
    Levels of antibody biomarkers of vector exposure
    Levels of knowledge, attitude and practice regarding malaria prevention among MMPs
    Focus group discussions
    Proportion of survey respondents (MMPs) who accept and are willing to use/ did use the personal protection package according to the protocol
    Questionnaire

    Full Information

    First Posted
    August 16, 2021
    Last Updated
    November 2, 2021
    Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    Health Poverty Action, Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR, National Centre for Parasitology, Entomology and Malaria Control, Cambodia
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05117567
    Brief Title
    Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
    Official Title
    A Personal Protection Package for Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia: A Stepped-wedge Trial With Nested Mixed-methods Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 1, 2021 (Anticipated)
    Primary Completion Date
    June 2022 (Anticipated)
    Study Completion Date
    June 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    Health Poverty Action, Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR, National Centre for Parasitology, Entomology and Malaria Control, Cambodia

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This stepped-wedge cluster-randomized controlled trial with nested mixed methods study will assess the effectiveness, acceptability, feasibility and cost-effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Lao People's Democratic Republic (PDR) and Cambodia.
    Detailed Description
    Over the last decade, the burden of malaria has fallen dramatically in the Greater Mekong Subregion, with deaths falling by 95% and cases by 76% between 2012 and 2019.The declining malaria burden in GMS has largely attributed by the deployment of interventions of malaria prevention tools such as long-lasting Insecticidal Nets (LLIN), and widespread availability of rapid diagnostic tests and artemisinin combination therapies. However, residual transmission still exists among high risk populations, particularly mobile and migrant populations who enter forests for work. New interventions targetting these high risk groups are needed if countries of the Greater Mekong Subregion are to achieve malaria elimination by 2030. The study will be conducted in malaria endemic areas of Lao PDR (Attapeu, Saravanh, Savannakhet and Khammouane Provinces) and Cambodia (Preah Vihear, Stung Treng and Ratanakiri Provinces) which have large forest going MMP populations. The aim of the study is to assess the effectiveness, acceptability, feasibility and cost-effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Lao People's Democratic Republic (PDR) and Cambodia. The personal protection package comprises a long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and a behavioural change communication (BCC) package tailored to mobile and migrant populations. The study design is a stepped-wedge cluster-randomized controlled trial with nested mixed methods study. The stepped-wedge cluster randomized trial will estimate the effectiveness of a personal protection package provided to forest-going MMPs (the intervention) delivered by village malaria volunteers at the site (village/worksite) level on reducing Plasmodium spp. infections. Whilst the personal protection package will be provided to mobile and migrant populations in each village in a step-wise manner, primary and secondary outcomes relating to malaria testing will be collected in all consenting individuals in the village who present for malaria rapid diagnostic tests, whether they are mobile and migrant people or not. The open stepped-wedge cluster-randomised controlled trial, randomized at the volunteer level (i.e. the volunteer and the village / workplaces they service), will be implemented between July 2021 to June 2022. The personal protection package for MMPs will be implemented sequentially in a minimum of ~488 villages serviced by approximately ~488 VMWs (~428 in Lao PDR and ~60 in Cambodia). Villages from each country will be randomised into 11 ordered blocks, with blocks transitioned from control (no personal protection package) to intervention (distribution of personal protection package) states at monthly intervals (10 blocks of 44 villages for the first 10 steps and a block of 48 villages transitioned at the last step). This follows an initial baseline control period of one-month at the start of the study Approximately 11 RDTs per month will be undertaken in each study site (village/ worksite). Given the design we estimate that the study has power to detect a relative minimum detectable difference of 34% (OR = 0.66) in odds of RDT-detectable malaria infection due to the intervention (assuming a village intraclass correlation [ICC]= 0.42; 5% significance; 90% power and 1% RDT malaria prevalence). For the stepped-wedged cluster randomized trial, both descriptive and primary outcome trial analyses will be performed. Using Stata version 15, differences in prevalence of Plasmodium spp. infections will be estimated across intervention and control periods using generalized linear mixed modelling (e.g. logit link function and binomial distribution) with crossed random effects for village and time, and intervention state, time and seasonality estimated as independent fixed factors. Temporal and spatial trends of Plasmodium spp. infections will also be explored including analysis of the effectiveness of the intervention across the study period. We will also explore any village-specific heterogeneity in effect by specifying a random effect for the intervention. Generalised linear mixed modelling will be extended to include model terms for country (main and interaction effects), and these will used to assess the extent of country-specific heterogeneity in intervention effect. The same approach will be used to assess risk group-specific heterogeneity (MMP, forest-goer, villager) in intervention effect.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Plasmodium Infection
    Keywords
    malaria, prevention, vector, migrant, elimination, vivax, falciparum, community-delivered, intervention

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    Stepped-wedge cluster-randomized controlled trial (one-way crossover) with nested mixed methods study
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    5868 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Personal protection package
    Arm Type
    Experimental
    Arm Description
    A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and mobile and migrant population-tailored behavioural change communication (BCC) package
    Arm Title
    Control
    Arm Type
    No Intervention
    Arm Description
    No personal protection package
    Intervention Type
    Combination Product
    Intervention Name(s)
    Personal protection package
    Intervention Description
    A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and MMP-tailored behavioural change communication (BCC) package
    Primary Outcome Measure Information:
    Title
    Plasmodium spp. infection diagnosed by RDT
    Description
    Change in the number of Plasmodium spp. infections detected by RDT per week per village
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Secondary Outcome Measure Information:
    Title
    Symptomatic malaria diagnosed by RDT
    Description
    Change in the number of symptomatic Plasmodium spp. infections detected by RDT per week per village
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on RDT cassette samples
    Description
    Change in the prevalence of Plasmodium spp. infection as determined by polymerase chain reaction (PCR) from RDT cassette samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on dried blood spot samples
    Description
    Change in the prevalence of Plasmodium spp. infection as determined by polymerase chain reaction (PCR) from dried blood spot (DBS) samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Plasmodium spp. infections with drug resistance mutations
    Description
    Change in the prevalence of Plasmodium spp. infection with drug resistance mutations.
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Prevalence of antibodies to Plasmodium spp.
    Description
    Prevalence of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of antibodies to Plasmodium spp.
    Description
    Levels of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Prevalence of antibodies to vector salivary antigens
    Description
    Levels of antibody biomarkers of vector exposure
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of antibodies to vector salivary antigens
    Description
    Levels of antibody biomarkers of vector exposure
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of knowledge, attitude and practice regarding malaria prevention among MMPs
    Description
    Focus group discussions
    Time Frame
    At approximately 12 months
    Title
    Proportion of survey respondents (MMPs) who accept and are willing to use/ did use the personal protection package according to the protocol
    Description
    Questionnaire
    Time Frame
    At approximately 12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion: Mobile and migrant individuals aged 18 years and over in selected villages including: Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups) Seasonal agricultural laborers Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo) Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.) Formal and informal cross-border migrant workers For qualitative research component, local health stakeholders meeting the following criteria will be eligible: Aged 18 years and over The local health stakeholders such as health centre staff, Operational District Malaria Supervisor (ODMS), and Provincial Malaria Supervisor (PMS), and basic health staff such as malaria unit staff in health centres, midwives, health assistants, district health officers and district focal person from CMPE and CNM Health staff members from HPA and Lao malaria community service organisations Exclusion: A village will be excluded from the study if: The village has an VHV/VMW program operated by any organizations other than CMPE, CNM, HPA, malaria CSOs in Lao PDR The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020) The village has no MMPs The village has no VHV/VMW The village has a government health facility for provision of malaria services
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Freya JI Fowkes, DPhil
    Phone
    +613 8506 2310
    Email
    freya.fowkes@burnet.edu.au
    First Name & Middle Initial & Last Name or Official Title & Degree
    Julia C Cutts, PhD
    Phone
    +61408397376
    Email
    julia.cutts@burnet.edu.au

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    36153501
    Citation
    Htike W, Oo WH, Lynn T, Sovanda L, Agius PA, Oo MC, Galau NH, Thu KM, Zaw AK, Htwe EP, Cutts JC, Kearney EA, Scott N, O'Flaherty K, Wang B, Khamlome B, Vilay P, Siv S, Fowkes FJI. Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial. BMC Infect Dis. 2022 Sep 24;22(1):747. doi: 10.1186/s12879-022-07724-5.
    Results Reference
    derived

    Learn more about this trial

    Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia

    We'll reach out to this number within 24 hrs